Related Experiment Video
Updated: Jul 29, 2026

Prediction and Validation of Gene Regulatory Elements Activated During Retinoic Acid Induced Embryonic Stem Cell Differentiation
Published on: June 21, 2016
Transformation suppressor activity of a Jun transcription factor lacking its activation domain
A Lloyd1, N Yancheva, B Wasylyk
1LGME-CNRS, U184-INSERM, Institut de Chimie Biologique, Faculté de Medecine, Strasbourg, France.
Abstract:
The oncoprotein c-Jun is thought to be a mediator of ras transformation as both its synthesis and activity as a transcription factor are stimulated by ras expression. But c-Jun co-operates with ras in transformation assays, suggesting that they act along different pathways (reviewed in ref. 4). Here we show by means of a dominant-negative mutated transcription factor that c-Jun potentially in conjunction with other factors that interact with it is necessary for transformation by ras. The mutant Jun lacks an activation domain and blocks stimulation of transcription by several oncoproteins, including Ras, v-Src, polyoma middle T, c-Jun and c-Fos, as well as by the tumour promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). The inhibition is specific for motifs that bind Jun: activation of an NF-kappa B/Rel motif is not affected. This Jun mutant acts as an anti-oncogene in ras-transformed cells, generating non-transformed revertants that have acquired anchorage and density-dependent growth, as well as reduced tumorigenicity in vivo. Mutants of other transcription factors designed to inhibit transformation will enable us to study their role in signal transduction.
Insights
The oncoprotein c-Jun is essential for Ras-mediated cell transformation. A dominant-negative Jun mutant inhibits Ras transformation and restores normal cell growth, acting as an anti-oncogene.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Transformation
Background:
- The oncoprotein c-Jun is implicated in Ras-mediated cell transformation.
- Both c-Jun synthesis and transcription factor activity are upregulated by Ras.
- c-Jun and Ras cooperate in transformation assays, suggesting distinct but interacting pathways.
Purpose of the Study:
- To investigate the necessity of c-Jun, potentially with interacting factors, for Ras-mediated cell transformation.
- To characterize a dominant-negative Jun mutant's effect on transcription and cell transformation.
- To explore the potential of Jun mutants as anti-oncogenes.
Main Methods:
- Utilized a dominant-negative mutated transcription factor (Jun mutant) lacking an activation domain.
- Assessed the inhibition of transcription stimulation by various oncoproteins and a tumor promoter (TPA).
- Examined the specificity of inhibition for Jun-binding motifs, contrasting with NF-kappa B/Rel motif activation.
- Evaluated the Jun mutant's anti-oncogenic activity in Ras-transformed cells, assessing growth characteristics and tumorigenicity.
Main Results:
- The dominant-negative Jun mutant specifically blocks transcription stimulation mediated by Ras and other oncoproteins.
- Inhibition is specific to Jun-binding motifs, leaving NF-kappa B/Rel activation unaffected.
- The Jun mutant functions as an anti-oncogene in Ras-transformed cells, inducing reversion to non-transformed phenotypes.
- Revertant cells exhibit restored anchorage and density-dependent growth and reduced in vivo tumorigenicity.
Conclusions:
- c-Jun, potentially with interacting partners, is necessary for Ras-mediated cell transformation.
- Dominant-negative Jun mutants can serve as anti-oncogenes, reversing oncogenic phenotypes.
- This approach offers a method to study the role of transcription factors in signal transduction and transformation.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
Master Transcription Regulators

